Crossmark

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study

Crossref DOI link: https://doi.org/10.1007/s13300-018-0452-y

Published Online: 2018-06-01

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fadini, Gian Paolo http://orcid.org/0000-0002-6510-2097
,

Bottigliengo, Daniele

D’Angelo, Federica

Cavalot, Franco

Bossi, Antonio Carlo

Zatti, Giancarlo

Baldi, Ileana

Avogaro, Angelo
Funding

Funding for this research was provided by:

Italian Diabetes Society

AstraZeneca
More Information

Article History

Received: 3 May 2018

First Online: 1 June 2018

Document is current

Any future updates will be listed below